145 related articles for article (PubMed ID: 2835737)
21. J774A.1 macrophage cell line produces PDGF-like and non-PDGF-like growth factors for bone cells.
Cheng SL; Rifas L; Shen V; Tong B; Pierce G; Deuel T; Peck WA
J Bone Miner Res; 1987 Oct; 2(5):467-74. PubMed ID: 3455630
[TBL] [Abstract][Full Text] [Related]
22. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
[TBL] [Abstract][Full Text] [Related]
23. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
Benito M; Lorenzo M
Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
[TBL] [Abstract][Full Text] [Related]
24. Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells.
Boensch C; Huang SS; Connolly DT; Huang JS
J Biol Chem; 1999 Apr; 274(15):10582-9. PubMed ID: 10187853
[TBL] [Abstract][Full Text] [Related]
25. Simian sarcoma virus transformation of normal rat kidney fibroblasts is associated with markedly increased basic fibroblast growth factor expression.
Milner PG
Biochem Biophys Res Commun; 1991 Oct; 180(1):423-30. PubMed ID: 1656977
[TBL] [Abstract][Full Text] [Related]
26. Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product.
Johnsson A; Betsholtz C; von der Helm K; Heldin CH; Westermark B
Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1721-5. PubMed ID: 2984666
[TBL] [Abstract][Full Text] [Related]
27. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor: a multifunctional regulator of normal and abnormal cell growth.
Deuel TF; Silverman NJ; Kawahara RS
Biofactors; 1988 Oct; 1(3):213-7. PubMed ID: 2855705
[TBL] [Abstract][Full Text] [Related]
29. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
30. Normal developing rat brain expresses a platelet-derived growth factor B chain (c-sis) mRNA truncated at the 5' end.
Sasahara M; Amano S; Sato H; Yang JG; Hayase Y; Kaneko M; Sato I; Suzaki M; Hazama F
Oncogene; 1998 Mar; 16(12):1571-8. PubMed ID: 9569024
[TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor/sis in normal and neoplastic cell growth.
Deuel TF; Pierce GF; Yeh HJ; Shawver LK; Milner PG; Kimura A
J Cell Physiol Suppl; 1987; Suppl 5():95-9. PubMed ID: 2824537
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of PDGF by cultured human T cells transformed with HTLV-I and II.
Pantazis P; Sariban E; Bohan CA; Antoniades HN; Kalyanaraman VS
Oncogene; 1987; 1(3):285-9. PubMed ID: 2838779
[TBL] [Abstract][Full Text] [Related]
33. Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus.
Johnsson A; Betsholtz C; Heldin CH; Westermark B
Nature; 1985 Oct 3-9; 317(6036):438-40. PubMed ID: 2995828
[TBL] [Abstract][Full Text] [Related]
34. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
35. The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF alpha and beta receptors intracellularly and initiate cellular transformation.
Bejcek BE; Hoffman RM; Lipps D; Li DY; Mitchell CA; Majerus PW; Deuel TF
J Biol Chem; 1992 Feb; 267(5):3289-93. PubMed ID: 1310684
[TBL] [Abstract][Full Text] [Related]
36. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
Kujoth GC; Fahl WE
Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
[TBL] [Abstract][Full Text] [Related]
37. Basic fibroblast-like growth factor is present in the conditioned medium of simian sarcoma virus transformed NRK cells.
Hicks K; Friedman B; Rosner MR
Biochem Biophys Res Commun; 1989 Nov; 164(3):1323-30. PubMed ID: 2556126
[TBL] [Abstract][Full Text] [Related]
38. Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation.
Lokeshwar VB; Huang SS; Huang JS
J Biol Chem; 1990 Jan; 265(3):1665-75. PubMed ID: 2153139
[TBL] [Abstract][Full Text] [Related]
39. Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells.
Deuel TF; Huang JS; Huang SS; Stroobant P; Waterfield MD
Science; 1983 Sep; 221(4618):1348-50. PubMed ID: 6310754
[TBL] [Abstract][Full Text] [Related]
40. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells.
Iglesias T; Llanos S; López-Barahona M; Seliger B; Rodríguez-Peña A; Bernal J; Muñoz A
Oncogene; 1995 Mar; 10(6):1103-10. PubMed ID: 7700635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
